Eli Lilly ( LLY - news - people )'s bone-building osteoporosis drug Forteo, or parathyroid hormone.

FORBES: Health

Lilly also said it is close to gaining approval on Forteo.

FORBES: Magazine Article

Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis drug Forteo have both been approved by the FDA and launched in the past few months.

FORBES: Lilly's And Schering's Blockbuster Hangovers

MicroChips' first trial will evaluate whether one implanted device, installed during a simple outpatient operation, can replace a year of daily injections of a generic version of Eli Lilly's bone-building osteoporosis drug Forteo, or parathyroid hormone.

FORBES: Magazine Article